Third Ebitda vs Net Income From Continuing Ops Analysis

THRD Stock

USD 12.44 0.03 0.24%

Third Harmonic financial indicator trend analysis is much more than just breaking down Third Harmonic Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Third Harmonic Bio is a good investment. Please check the relationship between Third Harmonic Ebitda and its Net Income From Continuing Ops accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Third Harmonic Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Ebitda vs Net Income From Continuing Ops

Ebitda vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Third Harmonic Bio Ebitda account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have totally related.

The correlation between Third Harmonic's Ebitda and Net Income From Continuing Ops is 0.99. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Third Harmonic Bio, assuming nothing else is changed. The correlation between historical values of Third Harmonic's Ebitda and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Third Harmonic Bio are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Ebitda i.e., Third Harmonic's Ebitda and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ebitda

Net Income From Continuing Ops

Most indicators from Third Harmonic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Third Harmonic Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Third Harmonic Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

As of November 26, 2024, Selling General Administrative is expected to decline to about 10.4 M. Issuance Of Capital Stock is expected to grow at the current pace this year

	2010	2023	2024 (projected)
Net Interest Income	2.6M	13.1M	8.6M
Interest Expense	10.6M	2.3M	2.2M

Net Interest Income Interest Expense

Third Harmonic fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital	Common Stock	Short Long Term Debt Total	Non Currrent Assets Other	Short Term Debt
Total Assets		0.67	0.94	0.93	-0.57	-0.93	-0.98	-0.94	0.96	1.0	1.0	0.55	-0.05	0.98	0.96	-0.01	0.93	1.0	0.94	-0.95	1.0	0.94	-0.53	0.66	0.67
Other Current Liab	0.67		0.88	0.36	-0.36	-0.89	-0.69	-0.61	0.84	0.67	0.67	0.42	0.64	0.53	0.83	0.66	0.36	0.67	0.39	-0.82	0.67	0.39	-0.37	0.29	0.25
Total Current Liabilities	0.94	0.88		0.74	-0.56	-1.0	-0.94	-0.89	1.0	0.94	0.94	0.56	0.27	0.86	1.0	0.31	0.74	0.94	0.78	-0.99	0.94	0.78	-0.53	0.6	0.59
Total Stockholder Equity	0.93	0.36	0.74		-0.53	-0.73	-0.9	-0.88	0.8	0.93	0.93	0.5	-0.39	0.98	0.79	-0.36	1.0	0.93	0.99	-0.78	0.93	0.99	-0.48	0.65	0.68
Other Liab	-0.57	-0.36	-0.56	-0.53		0.56	0.7	0.8	-0.55	-0.57	-0.57	-0.95	0.26	-0.54	-0.57	0.24	-0.53	-0.57	-0.57	0.63	-0.57	-0.57	0.99	-0.92	-0.85
Net Tangible Assets	-0.93	-0.89	-1.0	-0.73	0.56		0.94	0.89	-0.99	-0.93	-0.93	-0.58	-0.28	-0.85	-0.99	-0.31	-0.73	-0.93	-0.76	0.98	-0.93	-0.76	0.54	-0.59	-0.57
Net Debt	-0.98	-0.69	-0.94	-0.9	0.7	0.94		0.98	-0.96	-0.98	-0.98	-0.71	0.07	-0.96	-0.95	0.04	-0.9	-0.98	-0.91	0.95	-0.98	-0.91	0.67	-0.74	-0.72
Retained Earnings	-0.94	-0.61	-0.89	-0.88	0.8	0.89	0.98		-0.9	-0.94	-0.94	-0.75	0.13	-0.92	-0.92	0.1	-0.88	-0.94	-0.92	0.94	-0.94	-0.92	0.76	-0.86	-0.85
Accounts Payable	0.96	0.84	1.0	0.8	-0.55	-0.99	-0.96	-0.9		0.96	0.96	0.56	0.2	0.9	1.0	0.24	0.8	0.96	0.82	-0.99	0.96	0.82	-0.52	0.59	0.59
Cash	1.0	0.67	0.94	0.93	-0.57	-0.93	-0.98	-0.94	0.96		1.0	0.55	-0.04	0.98	0.96	-0.01	0.93	1.0	0.94	-0.95	1.0	0.94	-0.53	0.66	0.67
Cash And Short Term Investments	1.0	0.67	0.94	0.93	-0.57	-0.93	-0.98	-0.94	0.96	1.0		0.55	-0.04	0.98	0.96	-0.01	0.93	1.0	0.94	-0.95	1.0	0.94	-0.53	0.66	0.67
Common Stock Shares Outstanding	0.55	0.42	0.56	0.5	-0.95	-0.58	-0.71	-0.75	0.56	0.55	0.55		-0.26	0.54	0.55	-0.23	0.5	0.55	0.51	-0.59	0.55	0.51	-0.98	0.78	0.67
Non Current Liabilities Total	-0.05	0.64	0.27	-0.39	0.26	-0.28	0.07	0.13	0.2	-0.04	-0.04	-0.26		-0.22	0.21	1.0	-0.39	-0.04	-0.33	-0.2	-0.05	-0.33	0.25	-0.27	-0.27
Other Current Assets	0.98	0.53	0.86	0.98	-0.54	-0.85	-0.96	-0.92	0.9	0.98	0.98	0.54	-0.22		0.89	-0.19	0.98	0.98	0.98	-0.88	0.98	0.98	-0.5	0.64	0.65
Other Stockholder Equity	0.96	0.83	1.0	0.79	-0.57	-0.99	-0.95	-0.92	1.0	0.96	0.96	0.55	0.21	0.89		0.25	0.79	0.96	0.83	-1.0	0.96	0.83	-0.53	0.64	0.64
Total Liab	-0.01	0.66	0.31	-0.36	0.24	-0.31	0.04	0.1	0.24	-0.01	-0.01	-0.23	1.0	-0.19	0.25		-0.36	-0.01	-0.3	-0.24	-0.01	-0.3	0.23	-0.25	-0.24
Net Invested Capital	0.93	0.36	0.74	1.0	-0.53	-0.73	-0.9	-0.88	0.8	0.93	0.93	0.5	-0.39	0.98	0.79	-0.36		0.93	0.99	-0.78	0.93	0.99	-0.48	0.65	0.68
Total Current Assets	1.0	0.67	0.94	0.93	-0.57	-0.93	-0.98	-0.94	0.96	1.0	1.0	0.55	-0.04	0.98	0.96	-0.01	0.93		0.94	-0.95	1.0	0.94	-0.53	0.66	0.67
Capital Stock	0.94	0.39	0.78	0.99	-0.57	-0.76	-0.91	-0.92	0.82	0.94	0.94	0.51	-0.33	0.98	0.83	-0.3	0.99	0.94		-0.83	0.94	1.0	-0.51	0.73	0.76
Non Current Liabilities Other	-0.95	-0.82	-0.99	-0.78	0.63	0.98	0.95	0.94	-0.99	-0.95	-0.95	-0.59	-0.2	-0.88	-1.0	-0.24	-0.78	-0.95	-0.83		-0.95	-0.83	0.59	-0.7	-0.69
Net Working Capital	1.0	0.67	0.94	0.93	-0.57	-0.93	-0.98	-0.94	0.96	1.0	1.0	0.55	-0.05	0.98	0.96	-0.01	0.93	1.0	0.94	-0.95		0.94	-0.53	0.66	0.67
Common Stock	0.94	0.39	0.78	0.99	-0.57	-0.76	-0.91	-0.92	0.82	0.94	0.94	0.51	-0.33	0.98	0.83	-0.3	0.99	0.94	1.0	-0.83	0.94		-0.51	0.73	0.76
Short Long Term Debt Total	-0.53	-0.37	-0.53	-0.48	0.99	0.54	0.67	0.76	-0.52	-0.53	-0.53	-0.98	0.25	-0.5	-0.53	0.23	-0.48	-0.53	-0.51	0.59	-0.53	-0.51		-0.87	-0.78
Non Currrent Assets Other	0.66	0.29	0.6	0.65	-0.92	-0.59	-0.74	-0.86	0.59	0.66	0.66	0.78	-0.27	0.64	0.64	-0.25	0.65	0.66	0.73	-0.7	0.66	0.73	-0.87		0.99
Short Term Debt	0.67	0.25	0.59	0.68	-0.85	-0.57	-0.72	-0.85	0.59	0.67	0.67	0.67	-0.27	0.65	0.64	-0.24	0.68	0.67	0.76	-0.69	0.67	0.76	-0.78	0.99

Click cells to compare fundamentals

Third Harmonic Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Third Harmonic Bio is a strong investment it is important to analyze Third Harmonic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Third Harmonic's future performance. For an informed investment choice regarding Third Stock, refer to the following important reports:

How To Invest In Third

Details

Is Third Stock a good investment?

Details

What is Third Harmonic's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Third Harmonic Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Third Harmonic. If investors know Third will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Third Harmonic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.97)

Return On Assets

(0.11)

Return On Equity

(0.14)

The market value of Third Harmonic Bio is measured differently than its book value, which is the value of Third that is recorded on the company's balance sheet. Investors also form their own opinion of Third Harmonic's value that differs from its market value or its book value, called intrinsic value, which is Third Harmonic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Third Harmonic's market value can be influenced by many factors that don't directly affect Third Harmonic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Third Harmonic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Third Harmonic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Third Harmonic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Third Ebitda vs Net Income From Continuing Ops Analysis

Ebitda vs Net Income From Continuing Ops

Ebitda vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Ebitda

Net Income From Continuing Ops

Third Harmonic fundamental ratios Correlations

Third Harmonic Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Other Stockholder Equity	+ 1.0	Total Current Liabilities

Non Current Liabilities Other	- 1.0	Other Stockholder Equity
Net Tangible Assets	- 1.0	Total Current Liabilities
Non Current Liabilities Other	- 0.99	Accounts Payable
Other Stockholder Equity	- 0.99	Net Tangible Assets
Accounts Payable	- 0.99	Net Tangible Assets
Non Current Liabilities Other	- 0.99	Total Current Liabilities